Please view the full content in the pdf above.
Pushing the Limits with Nanoknife®: A Promising New Technology in Localised Prostate Cancer Management
Caroline Charles,1 *Jean de la Rosette,2 *Mark Emberton33
M. Emberton has provided consultancy services to and received research funding from
AngioDynamics Inc., SonaCare Inc., Sophiris Inc., Trod Medical, GSK, and Sanofi; and provided training for AngioDynamics Inc., and SonaCare Inc. J. de la Rosette is a consultant for AngioDynamics Inc.
Funding for this article was provided by AngioDynamics.
- EMJ Urol. 2015;3:90-102.
- Urology, EAU17.
Each article is made available under the terms of the Creative Commons Attribution-Non Commercial 4.0 License.